BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 37654626)

  • 1. Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes.
    Qin T; Li S; Henry LE; Chou E; Cavalcante RG; Garb BF; D'Silva NJ; Rozek LS; Sartor MA
    Cancer Res Commun; 2023 Aug; 3(8):1701-1715. PubMed ID: 37654626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Hydroxymethylation highlights the heterogeneity in keratinization and cell junctions in head and neck cancers.
    Liu S; de Medeiros MC; Fernandez EM; Zarins KR; Cavalcante RG; Qin T; Wolf GT; Figueroa ME; D'Silva NJ; Rozek LS; Sartor MA
    Clin Epigenetics; 2020 Nov; 12(1):175. PubMed ID: 33203436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor (FGF), FGF receptor (FGFR), and cyclin D1 (CCND1) DNA methylation in head and neck squamous cell carcinomas is associated with transcriptional activity, gene amplification, human papillomavirus (HPV) status, and sensitivity to tyrosine kinase inhibitors.
    Bao Y; Gabrielpillai J; Dietrich J; Zarbl R; Strieth S; Schröck F; Dietrich D
    Clin Epigenetics; 2021 Dec; 13(1):228. PubMed ID: 34933671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression and DNA Methylation in Human Papillomavirus Positive and Negative Head and Neck Squamous Cell Carcinomas.
    Hinić S; Rich A; Anayannis NV; Cabarcas-Petroski S; Schramm L; Meneses PI
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
    Schrank TP; Kothari A; Weir WH; Stepp WH; Rehmani H; Liu X; Wang X; Sewell A; Li X; Tasoulas J; Kim S; Yarbrough G; Xie Y; Flamand Y; Marur S; Hayward MC; Wu D; Burtness B; Anderson KS; Baldwin AS; Yarbrough WG; Issaeva N
    Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216532120. PubMed ID: 37523561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Epigenomic Alterations in HPV16+ Head and Neck Squamous Cell Carcinomas.
    Berglund A; Muenyi C; Siegel EM; Ajidahun A; Eschrich SA; Wong D; Hendrick LE; Putney RM; Kim S; Hayes DN; Shibata D
    Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):858-869. PubMed ID: 35064062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.
    Fertig EJ; Markovic A; Danilova LV; Gaykalova DA; Cope L; Chung CH; Ochs MF; Califano JA
    PLoS One; 2013; 8(11):e78127. PubMed ID: 24223768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histoepigenetic analysis of HPV- and tobacco-associated head and neck cancer identifies both subtype-specific and common therapeutic targets despite divergent microenvironments.
    Carrero I; Liu HC; Sikora AG; Milosavljevic A
    Oncogene; 2019 May; 38(19):3551-3568. PubMed ID: 30655605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients' survival, immune cell infiltrates, mutational load, and interferon γ signature.
    Sailer V; Sailer U; Bawden EG; Zarbl R; Wiek C; Vogt TJ; Dietrich J; Loick S; Grünwald I; Toma M; Golletz C; Gerstner A; Kristiansen G; Bootz F; Scheckenbach K; Landsberg J; Dietrich D
    EBioMedicine; 2019 Oct; 48():341-352. PubMed ID: 31628024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus 16 DNA Methylation Patterns and Investigation of Integration Status in Head and Neck Cancer Cases.
    Zygouras I; Leventakou D; Pouliakis A; Panagiotou S; Tsakogiannis D; Konstantopoulos G; Logotheti E; Samaras M; Kyriakopoulou Z; Beloukas A; Pateras IS; Delides A; Psyrri A; Panayiotides IG; Yiangou M; Kottaridi C
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP1 Gene Methylation in Head and Neck Squamous Cell Cancer in HPV-Negative Patients.
    Jumaniyazova E; Aghajanyan A; Kurevlev S; Tskhovrebova L; Makarov A; Gordon K; Lokhonina A; Fatkhudinov T
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes.
    Keck MK; Zuo Z; Khattri A; Stricker TP; Brown CD; Imanguli M; Rieke D; Endhardt K; Fang P; Brägelmann J; DeBoer R; El-Dinali M; Aktolga S; Lei Z; Tan P; Rozen SG; Salgia R; Weichselbaum RR; Lingen MW; Story MD; Ang KK; Cohen EE; White KP; Vokes EE; Seiwert TY
    Clin Cancer Res; 2015 Feb; 21(4):870-81. PubMed ID: 25492084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
    van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
    Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide hypomethylation in head and neck cancer is more pronounced in HPV-negative tumors and is associated with genomic instability.
    Richards KL; Zhang B; Baggerly KA; Colella S; Lang JC; Schuller DE; Krahe R
    PLoS One; 2009; 4(3):e4941. PubMed ID: 19293934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
    Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
    J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune landscape in molecular subtypes of human papillomavirus-negative head and neck cancer.
    Xie M; Chaudhary R; Slebos RJC; Lee K; Song F; Poole MI; Hoening DS; Noel LC; Hernandez-Prera JC; Conejo-Garcia JR; Chung CH; Tan AC
    Mol Carcinog; 2024 Jan; 63(1):120-135. PubMed ID: 37750589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures.
    Zhang Y; Koneva LA; Virani S; Arthur AE; Virani A; Hall PB; Warden CD; Carey TE; Chepeha DB; Prince ME; McHugh JB; Wolf GT; Rozek LS; Sartor MA
    Clin Cancer Res; 2016 Sep; 22(18):4735-45. PubMed ID: 27091409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype.
    Brennan K; Koenig JL; Gentles AJ; Sunwoo JB; Gevaert O
    EBioMedicine; 2017 Mar; 17():223-236. PubMed ID: 28314692
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.